Background
Type: Article

Introduction of a novel cancer cell targeted fusion protein: DT386-BR2

Journal: Annals of Oncology (09237534)Year: 2018/03/01Volume: Issue:
Jahanian-Najafabadi A. Shafiee F.Rabbani Khorasgani M.a
BronzeDOI:10.1093/annonc/mdy047.031Language: English

Abstract


Author Keywords

cytotoxic agentDT386 BR2 fusion proteinfusion proteinunclassified drug